Cite
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
MLA
Sánchez-Cabo, Fátima, et al. “Subclinical Atherosclerosis and Accelerated Epigenetic Age Mediated by Inflammation: A Multi-Omics Study.” European Heart Journal, vol. 44, no. 29, Aug. 2023, pp. 2698–709. EBSCOhost, https://doi.org/10.1093/eurheartj/ehad361.
APA
Sánchez-Cabo, F., Fuster, V., Silla-Castro, J. C., González, G., Lorenzo-Vivas, E., Alvarez, R., Callejas, S., Benguría, A., Gil, E., Núñez, E., Oliva, B., Mendiguren, J. M., Cortes-Canteli, M., Bueno, H., Andrés, V., Ordovás, J. M., Fernández-Friera, L., Quesada, A. J., Garcia, J. M., … Lara-Pezzi, E. (2023). Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study. European Heart Journal, 44(29), 2698–2709. https://doi.org/10.1093/eurheartj/ehad361
Chicago
Sánchez-Cabo, Fátima, Valentín Fuster, Juan Carlos Silla-Castro, Gema González, Erika Lorenzo-Vivas, Rebeca Alvarez, Sergio Callejas, et al. 2023. “Subclinical Atherosclerosis and Accelerated Epigenetic Age Mediated by Inflammation: A Multi-Omics Study.” European Heart Journal 44 (29): 2698–2709. doi:10.1093/eurheartj/ehad361.